Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients-Reference-Cited by-同舟云学术

Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients

Published:2017-11 Issue:6 Volume:5 Page:1743-1745
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Vadasz Zahava,Tal Yuval,Rotem Menachem,Shichter-Confino Vered,Mahlab-Guri Keren,Graif Yael,Kessel Aharon,Agmon-Levin Nancy,Maoz-Segal Ramit,Kivity Shmuel,Benor Shira,Lachover-Roth Idit,Zeldin Yuri,Stein Migel,Toker Ori,Hassoun Gamal,Bezalel-Rosenberg Shira,Toubi Elias,Asher Ilan,Sthoeger Zev

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference9 articles.

1. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients;Toubi;Allergy,2004

2. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria;Saini;J Allergy Clin Immunol,2011

3. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria;Maurer;N Engl J Med,2013

4. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014

5. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis;Metz;J Dermato Sci,2013

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Omalizumab Treatment on Quality of Life and Activity of Chronic Spontaneous Urticaria;Eurasian Journal of Critical Care;2024-05-02

2. Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels;World Allergy Organization Journal;2024-05

3. Predictive value of the systemic immune inflammation index and systemic inflammatory response index on omalizumab drug survival in chronic spontaneous urticaria;Allergo Journal International;2023-12-12

4. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients;Acta Dermato-Venereologica;2023-08-30

5. Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation;The Journal of Allergy and Clinical Immunology: In Practice;2023-08